Basic Research
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 14, 2007; 13(22): 3071-3079
Published online Jun 14, 2007. doi: 10.3748/wjg.v13.i22.3071
Table 3 Effects of MLN64 recombinant adenoviral infection on hepatic cholesterol levels, biliary bile flow, and lipid secretion (mean ± SE)
Hepatic cholesterol
Biliary lipid secretion
UnesterifiedEsterBile flowCholesterolBile saltsPhospholipids
GroupLiver weight(mg/g liver weight)(mg/g liver weight)(μL/min/100 g body weight)(nmol/min/100 g body weight)(nmol/min/100 g body weight)(nmol/min/100 g body weight)
Ad.E1Δ1.32 ± 0.04 (n = 11)1.97 ± 0.080.20 ± 0.089.43 ± 0.76 (n = 8)2.75 ± 0.33254.1 ± 34.284.25 ± 5.5
Ad.MLN641.14 ± 0.04 (n = 16)a2.38 ± 0.08a0.21 ± 0.074.14 ± 0.61a1.38 ± 0.19a308.5 ± 45.454.64 ± 13.5